- 全部删除
您的购物车当前为空
SGC2085 HCl 是一种有效的选择性辅激活剂相关的精氨酸甲基转移酶 1 (CARM1) 抑制剂,IC50 为 50 nM,选择性比其他 PRMT 高出数倍。 CARM1 是结直肠癌中 Wnt/β-catenin 转录和肿瘤转化的重要正调节因子,也是雌激素刺激的乳腺癌生长的关键因素,其耗竭导致体内髓性白血病细胞增殖减少。

SGC2085 HCl 是一种有效的选择性辅激活剂相关的精氨酸甲基转移酶 1 (CARM1) 抑制剂,IC50 为 50 nM,选择性比其他 PRMT 高出数倍。 CARM1 是结直肠癌中 Wnt/β-catenin 转录和肿瘤转化的重要正调节因子,也是雌激素刺激的乳腺癌生长的关键因素,其耗竭导致体内髓性白血病细胞增殖减少。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 832 | In stock | |
| 2 mg | ¥ 1,490 | In stock | |
| 5 mg | ¥ 1,930 | In stock | |
| 10 mg | ¥ 3,500 | In stock | |
| 25 mg | ¥ 5,680 | In stock | |
| 50 mg | ¥ 7,930 | In stock | |
| 100 mg | ¥ 10,600 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,190 | In stock |
SGC2085 HCl 相关产品
| 产品描述 | SGC2085 is a potent and selective coactivator associated arginine methyltransferase 1 (CARM1) Inhibitor with an IC50 of 50 nM and more than undred-fold selectivity over other PRMTs. CARM1 is an important positive modulator of Wnt/β-catenin transcription and neoplastic transformation in colorectal cancer as well as a critical factor in estrogen-stimulated breast cancer growth, and its depletion results in decreased proliferation of myeloid leukemia cells in vivo. |
| 靶点活性 | CARM1:50 nM, PRMT6:5.2 μM |
| 分子量 | 348.87 |
| 分子式 | C19H24N2O2·HCl |
| CAS No. | 1821908-49-9 |
| Smiles | C(=O)([C@H](C)N)NCc1cc(c(cc1)Oc1cc(cc(c1)C)C)C.Cl |
| 密度 | no data available |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (157.65 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容